PEAK PHARMACEUTICALS, INC. Proceeds from Notes Payable
PEAK PHARMACEUTICALS, INC. (RMHI) reported Proceeds from Notes Payable of $240.00 thousand for the 12-month period ending 2021-09-30, per its 10-K filed 2022-12-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-12-19
- PEAK PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2021-09-30 was $197.50K.
- PEAK PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2018-06-30 was $20.00K.
- PEAK PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2017-06-30 was $0.00.
- PEAK PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2021 was $240.00K.
- PEAK PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2014 was $500.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2021-09-30 | $197.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-19 | $240.00K 10-K · filed 2022-12-19 | ||
| 2021-06-30 | $42.50K 10-Q · filed 2022-12-19 | |||
| 2018-06-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-13 | $43.00K 10-Q · filed 2018-08-13 | ||
| 2018-03-31 | $23.00K 10-Q · filed 2018-05-14 | |||
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-13 | $20.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-14 | |||
| 2014-09-30 | $500.00K 10-K · filed 2016-01-13 |